Resistance to activated protein C (APC) is the most prevalent inherited cause of venous thrombosis. The APC resistance phenotype is associated with a single point mutation in the factor V gene, changing Arg506 in the APC cleavage site to a Gln. We have investigated 50 Swedish families with inherited APC resistance for this mutation and found it to be present in 47 of them. Perfect cosegregation between a low APC ratio and the presence of mutation was seen in 40 families. In seven families, the co-segregation was not perfect as 12 out of 57 APC-resistant family members were found to lack the mutation. Moreover, in three families with APC resistance, the factor V gene mutation was not found, suggesting another still unidentified cause of inherited APC resistance. Of 308 investigated families members, 146 were normal, 144 heterozygotes, and 18 homozygotes for the factor V gene mutation and there were significant differences in thrombosis-free survival curves between these groups. By age 33 yr, 8% of normals, 20% of heterozygotes, and 40% of homozygotes had had manifestation of venous thrombosis.
B Zöller, P J Svensson, X He, B Dahlbäck
Title and authors | Publication | Year |
---|---|---|
Efficacy and safety of anti-Xa direct oral anticoagulants vs. warfarin in patients homozygous for Factor V Leiden and prothrombin G20210A mutations.
Dan O, Pikovsky O, Kerman T, Amar S, Rabinovich A |
Journal of thrombosis and thrombolysis | 2025 |
A Rare Presentation of Ascites Secondary to Inferior Vena Cava Thrombosis in a Patient With Factor V Leiden Mutation
Hwang S, Kaur D, Iskander M, Botelho P, Rachna V |
Cureus | 2024 |
Laboratory Testing for Activated Protein C Resistance (APCR): An Update.
Favaloro EJ, Mohammed S, Vong R, Pasalic L |
Methods in molecular biology (Clifton, N.J.) | 2023 |
Testing for Factor V Leiden (FVL) and Prothrombin G20210A Genetic Variants.
Pajič T |
Methods in molecular biology (Clifton, N.J.) | 2023 |
Impaired factor V–related anticoagulant mechanisms and deep vein thrombosis associated with A2086D and W1920R mutations
Shimonishi N, Ogiwara K, Yoshida J, Horie K, Nakajima Y, Furukawa S, Takeyama M, Nogami K |
Blood Advances | 2023 |
Association between Polymorphism eNOS4, tPA, Factor V Leiden, Prothrombin, and Methylenetetrahydrofolate Reductase and the Occurrence of Legg-Calvé-Perthes Disease.
Matuszewska A, Sygacz O, Matuszewski Ł, Stec S, Grzegorzewski A, Gągała J |
Journal of Clinical Medicine | 2023 |
The prognostic role of extended preoperative hypercoagulability work-up in high-risk microsurgical free flaps: a single-center retrospective case series of patients with heterozygotic factor V Leiden thrombophilia.
Falkner F, Thomas B, Aman M, Risse EM, Wittenberg G, Gazyakan E, Harhaus L, Bigdeli AK, Kneser U, Radu CA |
BMC surgery | 2022 |
Activated protein C has a regulatory role in factor VIII function
AR Wilhelm, NA Parsons, BJ Samelson-Jones, RJ Davidson, CT Esmon, RM Camire, LA George |
Blood | 2021 |
Osteonecrosis of the Femoral Head in Patients with Hypercoagulability—From Pathophysiology to Therapeutic Implications
E Rezus, BI Tamba, MC Badescu, D Popescu, I Bratoiu, C Rezus |
International journal of molecular sciences | 2021 |
Genetic risk factors for venous thromboembolism
B Zöller, PJ Svensson, B Dahlbäck, C Lind-Hallden, C Hallden, J Elf |
Expert Review of Hematology | 2020 |
Homozygous Factor V Leiden Thrombophilia in a Patient With Histologically Confirmed Thromboangiitis Obliterans
M Mensa, T Dobbs, ZM Jessop, IS Whitaker |
Clinical medicine insights. Case reports | 2019 |
The association between activated protein C ratio and Factor V Leiden are gender-dependent
RS Hansen, M Nybo |
Clinical Chemistry and Laboratory Medicine | 2019 |
Inferior vena cava syndrome in neonates: An evidence‐based systematic review of the literature
P Tieu, B Paes, A Ahmed, D Matino, A Chan, M Bhatt |
Pediatric Blood & Cancer | 2019 |
THE CONTRIBUTION OF CARRIER THE ALLELIC VARIANT G1691A OF THE GENE V OF COAGULATION FACTOR TO THE DEVELOPMENT OF THROMBOTIC COMPLICATIONS DEPENDING ON THE PRESENCE OF CARDIOVASCULAR RISK FACTORS IN INDIVIDUALS WITH SECONDARY LEUKOCYTOSIS, THROMBOCYTOSIS A
OY Mishcheniuk, OM Kostiukevych, LK Benkovska, AN Kravchenko |
2019 | |
Genetics of immunoglobulin-A vasculitis (Henoch-Schönlein purpura): An updated review
R López-Mejías, S Castañeda, F Genre, S Remuzgo-Martínez, FD Carmona, J Llorca, R Blanco, J Martín, MA González-Gay |
Autoimmunity Reviews | 2018 |
Factor V Leiden paradox in a middle-aged Swedish population: A prospective study
B Zöller, O Melander, PJ Svensson, G Engström |
Vascular medicine (London, England) | 2018 |
The influence of blood count, cardiovascular risks, inherited thrombophilia and JAK2 V617F burden allele on the type of thrombosis in patients with Ph(-) myeloproliferative neoplasms
I Horvat, A Boban, MR Antolic, R Serventi-Seiwerth, P Roncevic, I Radman, D Sertic, M Vodanovic, D Pulanic, S Basic-Kinda, N Durakovic, S Zupancic-Salek, R Vrhovac, I Aurer, D Nemet, R Zadro, B Labar |
Clinical Lymphoma, Myeloma & Leukemia | 2018 |
Reduced prothrombinase inhibition by tissue factor pathway inhibitor contributes to the factor V Leiden hypercoagulable state
JP Wood, LM Kreuziger, PE Ellery, SA Maroney, AE Mast |
Blood Advances | 2017 |
Hemostasis and Thrombosis
EJ Favaloro, G Lippi |
Hemostasis and Thrombosis | 2017 |
Evaluation of role of FV, FVIII and APLAs in the pathogenesis of APCR in FV Leiden negative DVT patients: a study in India
A Sharma, K Singh, A Biswas, R Ranjan, K Kishor, R Kumar, H Pandey, VK Kamal, R Saxena |
Journal of Thrombosis and Thrombolysis | 2017 |
New findings on venous thrombogenesis:
JR Byrnes, AS Wolberg |
Hämostaseologie | 2016 |
Pro- and anticoagulant properties of factor V in pathogenesis of thrombosis and bleeding disorders
B Dahlbäck |
International Journal of Laboratory Hematology | 2016 |
Identification and functional characterization of a novel F5 mutation (Ala512Val, FV B onn ) associated with activated protein C resistance
B Pezeshkpoor, E Castoldi, A Mahler, D Hanel, J Müller, NS Hamedani, A Biswas, J Oldenburg, A Pavlova |
Journal of Thrombosis and Haemostasis | 2016 |
Thrombophilic risk of individuals with rare compound factor V Leiden and prothrombin G20210A polymorphisms: an international case series of 100 individuals
MY Lim, AM Deal, S Kim, MD Musty, J Conard, P Simioni, F Dutrillaux, SS Eid, S Middeldorp, WM Halbmayer, B Boneu, M Moia, S Moll |
European Journal of Haematology | 2016 |
Frequency and association of 1691 (G>A) FVL, 20210 (G>A) PT and 677 (C>T) MTHFR with deep vein thrombosis in the population of Bosnia and Herzegovina
A Jusić-Karić, R Terzić, Z Jerkić, A Avdić, M Pođanin |
Balkan Journal of Medical Genetics | 2016 |
Principles of Critical Care in Obstetrics
A Gandhi, N Malhotra, J Malhotra, N Gupta, NM Bora |
2016 | |
Polymorphisms in factor V and antithrombin III gene in recurrent pregnancy loss: a case–control study in Indian population
A Sharma, T Bhakuni, R Ranjan, R Kumar, K Kishor, VK Kamal, M Mahapatra, MA Jairajpuri, R Saxena |
Journal of Thrombosis and Thrombolysis | 2015 |
Factor V Leiden and Cardiopulmonary Bypass
Victor Uppal, Mark Rosin, Jo-Anne Marcoux, Marnie Olson, Jennifer Bezaire, Gregory Dalshaug |
The Journal of Extra-Corporeal Technology | 2015 |
Prevalence of Factor V Genetic Variants Associated With Indian APCR Contributing to Thrombotic Risk
A Sharma, T Bhakuni, A Biswas, R Ranjan, R Kumar, K Kishore, M Mahapatra, MA Jairajpuri, R Saxena |
Clinical and Applied Thrombosis/Hemostasis | 2015 |
Novel FV mutation (W1920R, FVNara) associated with serious deep vein thrombosis and more potent APC resistance relative to FVLeiden
K Nogami, K Shinozawa, K Ogiwara, T Matsumoto, K Amano, K Fukutake, M Shima |
Blood | 2014 |
Impact of hormone-associated resistance to activated protein C on the thrombotic potential of oral contraceptives: a prospective observational study
H Rühl, L Schröder, J Müller, S Sukhitashvili, J Welz, WC Kuhn, J Oldenburg, C Rudlowski, B Pötzsch |
PloS one | 2014 |
Profile of prothrombotic factors in Indian children with ischemic stroke
R Konanki, S Gulati, R Saxena, AK Gupta, A Seith, A Kumar, A Saxena, M Kabra, V Kalra, R Lakshmy |
Journal of Clinical Neuroscience | 2014 |
Factor V Leiden mutation in women with early recurrent pregnancy loss: a meta-analysis and systematic review of the causal association
C Sergi, TA Jishi, M Walker |
Archives of Gynecology and Obstetrics | 2014 |
Increased activation of blood coagulation in pregnant women with the Factor V Leiden mutation
U Kjellberg, M Rooijen, K Bremme, M Hellgren |
Thrombosis Research | 2014 |
Impact of Hormone-Associated Resistance to Activated Protein C on the Thrombotic Potential of Oral Contraceptives: A Prospective Observational Study
H Rühl, L Schröder, J Müller, S Sukhitashvili, J Welz, WC Kuhn, J Oldenburg, C Rudlowski, B Pötzsch, I Ahrens |
PloS one | 2014 |
Correlation between thrombophilia and recurrent pregnancy loss in patients with polycystic ovary syndrome: A comparative study
T Kazerooni, F Ghaffarpasand, N Asadi, Z Dehkhoda, M Dehghankhalili, Y Kazerooni |
Journal of the Chinese Medical Association | 2013 |
eLS
YC Chang, YH Yu, LM Chuang |
Encyclopedia of Life Sciences | 2013 |
Prevalence of genetic risk factors related with thrombophilia and hypofibrinolysis in patients with osteonecrosis of the femoral head in Poland
J Gagala, M Buraczynska, T Mazurkiewicz, A Ksiazek |
BMC musculoskeletal disorders | 2013 |
Spontaneous neonatal arterial thromboembolism: infants at risk, diagnosis, treatment, and outcomes
G Rashish, BA Paes, K Nagel, AK Chan, S Thomas |
Blood Coagulation & Fibrinolysis | 2013 |
Multiple presence of prothrombotic risk factors in Croatian children with arterial ischemic stroke and transient ischemic attack
JL Krleža, V Ðuranović, A Bronić, DC Herak, V Mejaški-Bošnjak, R Zadro |
Croatian medical journal | 2013 |
Procoagulant Activity in Hemostasis and Thrombosis : Virchowʼs Triad Revisited
AS Wolberg, MM Aleman, K Leiderman, KR Machlus |
Anesthesia & Analgesia | 2012 |
Autoimmune diseases and venous thromboembolism: a review of the literature
B Zöller, X Li, J Sundquist, K Sundquist |
American Journal of Cardiovascular Disease | 2012 |
Interpreting Results From Factor V Leiden Mutation Analysis: A Cautionary Note
GD Sinclair, MC Poon |
Clinical and Applied Thrombosis/Hemostasis | 2012 |
Procoagulant Activity in Hemostasis and Thrombosis: Virchow’s Triad Revisited
AS Wolberg, MM Aleman, K Leiderman, KR Machlus |
Anesthesia & Analgesia | 2011 |
Encyclopedia of Life Sciences
B Dahlbäck |
Encyclopedia of Life Sciences | 2011 |
Factor V Leiden thrombophilia
JL Kujovich |
Genetics in Medicine | 2011 |
Medical history screening for thrombophilic risk: is this adequate?
W Eggert-Kruse, A Ziegler, S Horlbeck, T Strowitzki |
Fertility and Sterility | 2011 |
Vascular Behcet and Mutations in Thrombogenic Genes: Methylene Tetrahydrofolate Reductase, Factor V, and Prothrombin
E Dagan, Y Baruch, M Fiorilli, M Rozenbaum, I Rosner, R Gershoni-Baruch |
Genetic Testing and Molecular Biomarkers | 2011 |
Epidemiology of Activated Protein C Resistance and Factor V Leiden Mutation in the Mediterranean Region
MM Jadaon |
Mediterranean journal of hematology and infectious diseases | 2011 |
Acquired Activated Protein C Resistance, Thrombophilia and Adverse Pregnancy Outcomes: A Study Performed in an Irish Cohort of Pregnant Women
S Sedano-Balbás, M Lyons, B Cleary, M Murray, G Gaffney, M Maher |
Journal of Pregnancy | 2011 |
The anticoagulant function of coagulation factor V :
TJ Cramer, AJ Gale |
Thrombosis and Haemostasis | 2011 |
The anticoagulant function of coagulation factor V:
TJ Cramer, AJ Gale |
Thrombosis and Haemostasis | 2011 |
Impact of smoking during pregnancy on functional coagulation testing
D Dizon-Townson, C Miller, V Momirova, B Sibai, CY Spong, G Wendel, K Wenstrom, P Samuels, S Caritis, Y Sorokin, M Miodovnik, MJ O'Sullivan, D Conway, RJ Wapner, SG Gabbe |
American journal of perinatology | 2011 |
APC resistance: biological basis and acquired influences
E Castoldi, J Rosing |
Journal of Thrombosis and Haemostasis | 2010 |
Factor V Leiden mutation in Arabs in Kuwait by real-time PCR: different values for different Arabs
AA Dashti, MM Jadaon, HL Lewis |
Journal of Human Genetics | 2010 |
Thrombophilia screening – at the right time, for the right patient, with a good reason
M Stegnar |
Clinical Chemistry and Laboratory Medicine | 2010 |
Factor V Leiden mutation and pregnancy-related complications
U Kjellberg, M Rooijen, K Bremme, M Hellgren |
American Journal of Obstetrics and Gynecology | 2010 |
Factor V Leiden and FII 20210 testing in thromboembolic disorders
T Pajič |
Clinical Chemistry and Laboratory Medicine | 2010 |
High Prevalence of Activated Protein C Resistance and Factor V Leiden Mutation in an Arab Population and Patients With Venous Thrombosis in Kuwait
MM Jadaon, AA Dashti, HL Lewis |
Diagnostic Molecular Pathology | 2010 |
Detection of the imbalance of procoagulant versus anticoagulant factors in cirrhosis by a simple laboratory method
A Tripodi, M Primignani, L Lemma, V Chantarangkul, A Dell'Era, F Iannuzzi, A Aghemo, PM Mannucci |
Hepatology | 2010 |
APCR, factor V gene known and novel SNPs and adverse pregnancy outcomes in an Irish cohort of pregnant women
S Sedano-Balbás, M Lyons, B Cleary, M Murray, G Gaffney, M Maher |
BMC pregnancy and childbirth | 2010 |
Blood coagulation factors V and VIII: Molecular Mechanisms of Procofactor Activation
MH Bos, RM Camire |
Journal of coagulation disorders | 2010 |
Death after liposuction: case report and review of the literature
C Terranova, D Sartore, R Snenghi |
Medicine Science and the Law | 2010 |
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd |
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology | 2009 |
May-Thurner syndrome will be completed?
YD Bast, L Dahin |
Thrombosis Research | 2009 |
Massive Pulmonary Embolism Associated With Factor V Leiden, Prothrombin, and Methylenetetrahydrofolate Reductase Gene Mutations in a Young Patient on Oral Contraceptive Pills: A Case Report
KM Charafeddine, RA Mahfouz, GY Ibrahim, AT Taher, JJ Hoballah, AM Taha |
Clinical and Applied Thrombosis/Hemostasis | 2009 |
Advances in understanding pathogenic mechanisms of thrombophilic disorders
B Dahlback |
Blood | 2008 |
The Factor V Leiden mutation is associated with a higher blood haemoglobin concentration in women below 50 of the Malmö Thrombophilia Study (MATS)
N Isma, T Breslin, B Lindblad, PJ Svensson |
Journal of Thrombosis and Thrombolysis | 2008 |
THROMBOPHILIC RISK FACTORS IN PATIENTS WITH CRANIAL AND SPINAL DURAL ARTERIOVENOUS FISTULAE
R Gerlach, M Boehm-Weigert, J Berkefeld, J Duis, A Raabe, V Seifert, G Marquardt |
Neurosurgery | 2008 |
Oestrogen treatment of constitutional tall stature in girls: is there a risk of thrombosis or bleeding?
O Rask, KO Nilsson, E Berntorp |
Acta Paediatrica | 2008 |
Pulmonary Embolism in Medical Patients: An Autopsy-Based Study
N Kakkar, RK Vasishta |
Clinical and Applied Thrombosis/Hemostasis | 2008 |
Medicina dell’età prenatale
AL Borrelli, D Arduini, A Cardone, V Ventruto |
2008 | |
Arterial Thrombosis in Mice with Factor V Leiden Mutation
ES Sampram, Y Saad, K Ouriel |
Vascular | 2008 |
Combined Thrombophilic Mutations in Women with Unexplained Recurrent Miscarriage
A Sotiriadis, G Vartholomatos, M Pavlou, N Kolaitis, L Dova, T Stefos, E Paraskevaidis, SN Kalantaridou |
American Journal of Reproductive Immunology | 2007 |
Risk factors for venous thrombosis in Swedish children and adolescents
O Rask, E Berntorp, R Ljung |
Acta Paediatrica | 2007 |
Factor V mutations in Iranian patients with activated protein C resistance and venous thrombosis
R Chegeni, B Kazemi, A Hajifathali, AA Pourfathollah, GR Lari |
Thrombosis Research | 2007 |
Lower Contribution of Factor V Leiden or G202104 Mutations to Ischemic Stroke in Patients With Clinical Risk Factors: Pair-Matched Case-Control Study
D Eterović, M Titlić, V Čulić, R Zadro, D Primorac |
Clinical and Applied Thrombosis/Hemostasis | 2007 |
Utility of the Clinical Practice of Admnistering Thrombophilic Screening and Antithrombotic Prophylaxis with Low-Molecular-Weight Heparin to Healthy Donors Treated with G-Csf for Mobilization of Peripheral Blood Stem Cells
M Martino, F Luise, V Oriana, G Console, T Moscato, C Mammì, G Messina, E Massara, G Irrera, A Piromalli, VT Lombardo, C Laganà, P Lacopino |
TUMORI | 2007 |
Factor V Leiden as a Common Genetic Risk Factor for Venous Thromboembolism
MD Horne, DJ McCloskey |
Journal of Nursing Scholarship | 2006 |
Prevalence of factor V Leiden and prothrombin G20210A mutations in Chinese patients with deep venous thrombosis and pulmonary embolism
ZJ Jun, T Ping, Y Lei, L Li, SY Ming, W Jing |
Clinical and Laboratory Haematology | 2006 |
Different Genes and Polymorphisms Affecting High-Density Lipoprotein Cholesterol Levels in Greek Familial Hypercholesterolemia Patients
GV Dedoussis, S Maumus, DM Choumerianou, J Skoumas, C Pitsavos, C Stefanadis, S Visvikis-Siest |
Genetic Testing | 2006 |
Henoch–Schonlein purpura: polymorphisms in thrombophilia genes
E Dagan, R Brik, Y Broza, R Gershoni-Baruch |
Pediatric Nephrology | 2006 |
Thrombophilic mutations in Iranian patients with infertility and recurrent spontaneous abortion
R Behjati, MH Modarressi, M Jeddi-Tehrani, P Dokoohaki, J Ghasemi, AH Zarnani, M Aarabi, T Memariani, M Ghaffari, MA Akhondi |
Annals of Hematology | 2006 |
Hereditary thrombophilia
S Khan, JD Dickerman |
Thrombosis Journal | 2006 |
Functional single nucleotide polymorphism-based association studies
VE Carlton, JS Ireland, F Useche, M Faham |
Human genomics | 2006 |
The Leiden mutation and activated protein C resistance as risk factors for disseminated intravascular coagulation in acutely poisoned patients
Mirosław Prazanowski, Barbara Kur, Małgorzata Barańska, Waldemar Lutz, Bozena Piłacik, Zbigniew Kolaciński |
Clinical Toxicology | 2006 |
Henoch–Schonlein purpura: polymorphisms in thrombophilia genes
E Dagan, R Brik, Y Broza, R Gershoni-Baruch |
Pediatric Nephrology | 2006 |
Arterial thrombosis associated with heterozygous factor V Leiden disorder, hyperhomocysteinemia, and peripheral arterial disease: Importance of synergistic factors
C Page, LE Rubin, RJ Gusberg, A Dardik |
Journal of Vascular Surgery | 2005 |
Detection of the Factor V Leiden Mutation in Iranian Patients with Venous Thrombosis
RC ., BK ., AH ., AP ., GR ., MA ., MT ., YM . |
Biotechnology(Faisalabad) | 2005 |
Coagulation Factor V Mutations in Iranian Patients with Venous Thrombosis
AH ., BK ., AP ., GR ., RC . |
Pakistan Journal of Biological Sciences | 2005 |
The incidence of venous thromboembolism among Factor V Leiden carriers: a community-based cohort study
JA Heit, JL Sobell, H Li, SS Sommer |
Journal of Thrombosis and Haemostasis | 2005 |
THE JOHN CHARNLEY AWARD: Heritable Thrombophilia and Development of Thromboembolic Disease after Total Hip Arthroplasty
EA Salvati, AG Valle, GH Westrich, AJ Rana, L Specht, BB Weksler, P Wang, CJ Glueck |
Clinical Orthopaedics and Related Research | 2005 |
The Role of Factor V Leiden and Prothrombin G20210a Mutations in Sudden Sensorineural Hearing Loss
K G??r??r, Tuncer, G Eskandari, C ??zcan, M ??nal, C ??zsahinoglu |
Otology & Neurotology | 2005 |
The Relationship of the Factor V Leiden Mutation and Pregnancy Outcomes for Mother and Fetus
D Dizon-Townson, C Miller, B Sibai, CY Spong, E Thom, G Wendel, K Wenstrom, P Samuels, MA Cotroneo, A Moawad, Y Sorokin, P Meis, M Miodovnik, MJ O’Sullivan, D Conway, RJ Wapner, SG Gabbe |
Obstetrics & Gynecology | 2005 |
THE JOHN CHARNLEY AWARD: Heritable Thrombophilia and Development of Thromboembolic Disease after Total Hip Arthroplasty:
EA Salvati, AG Valle, GH Westrich, AJ Rana, L Specht, BB Weksler, P Wang, CJ Glueck |
Clinical Orthopaedics and Related Research | 2005 |
Risk factors for venous thrombosis in Swedish children and adolescents: Venous thrombosis in children and adolescents
O Rask, E Berntorp, R Ljung |
Acta Paediatrica | 2005 |
Renin–angiotensin system and haemostasis gene polymorphisms and outcome after coronary artery bypass graft surgery
H Völzke, V Kleine, DM Robinson, R Grimm, S Hertwig, C Schwahn, L Eckel, R Rettig |
International Journal of Cardiology | 2005 |
Risk factors for venous thrombosis in Swedish children and adolescents
O Rask, E Berntorp, R Ljung |
Acta paediatrica (Oslo, Norway : 1992) | 2005 |
The multiple faces of the partial thromboplastin time APTT
B Dahlback |
Journal of Thrombosis and Haemostasis | 2004 |
Factor V Leiden and Perioperative Risk
BS Donahue |
Anesthesia & Analgesia | 2004 |
APC resistance: What have we learned since 1993? / APC-Resistenz: Was haben wir seit 1993 hinzugelernt?
B Dahlbäck |
LaboratoriumsMedizin | 2004 |
Prevalence of resistance against activated protein C resulting from factor V leiden is significantly increased in myocardial infarction: Investigation of 507 patients with myocardial infarction
K Middendorf, P Göhring, TY Huehns, D Seidel, G Steinbeck, S Nikol |
American Heart Journal | 2004 |
M385T polymorphism in the factor V gene, but not Leiden mutation, is associated with placental abruption in Finnish women
E Jääskeläinen, S Toivonen, EL Romppanen, S Helisalmi, L Keski-Nisula, K Punnonen, S Heinonen |
Placenta | 2004 |
Syndrome hémorragique fœtal
JM Jouannic |
EMC - Hematologie | 2004 |
Factor V Leiden and Contraception
L Ament |
Journal of Midwifery & Women s Health | 2004 |
The Predictability of Factor V Leiden (FV:Q506) Gene Mutation via Clotting-Based Diagnosis of Activated Protein C Resistance
N Sayınalp, IC Haznedaroğlu, S Aksu, Y Büyükaşık, H Göker, H Parlak, OI Özcebe, Ş Kirazlı, SV Dündar, A Gürgey |
Clinical and Applied Thrombosis/Hemostasis | 2004 |
THE 2003 MARSHALL R. URIST AWARD PAPER: Genetic Background of Osteonecrosis: Associated with Thrombophilic Mutations?
CG Zalavras, G Vartholomatos, E Dokou, KN Malizos |
Clinical Orthopaedics and Related Research® | 2004 |
Factor V Leiden and the prothrombin 20210A gene mutation and osteonecrosis of the knee
A Bjrkman, IM Burtscher, PJ Svensson, A Hillarp, J Besjakov, G Benoni |
Archives of Orthopaedic and Trauma Surgery | 2004 |
Factor V Leiden and Prothrombin Gene Mutation: Risk Factors for Osteonecrosis of the Femoral Head in Adults
A Bjrkman, PJ Svensson, A Hillarp, IM Burtscher, A Rnow, G Benoni |
Clinical Orthopaedics and Related Research® | 2004 |
Principles of Molecular Pathology
AA Killeen |
2004 | |
Airline Chair-Rest Deconditioning: Induction of Immobilisation Thromboemboli?
JE Greenleaf, NJ Rehrer, SR Mohler, DT Quach, DG Evans |
Sports Medicine | 2004 |
Antiphospholipid antibodies and thrombosis: association with acquired activated protein C resistance in venous thrombosis and with hyperhomocysteinemia in arterial thrombosis.
Kassis J, Neville C, Rauch J, Busque L, Chang ER, Joseph L, Le Comte M, Subang R, Fortin PR |
Thrombosis and haemostasis | 2004 |
The discovery of activated protein C resistance
B Dahlb��ck |
Journal of Thrombosis and Haemostasis | 2003 |
Coagulation factor V G allele and HR2 haplotype
H Kostka, T Schwarz, S Schellong, C Mix, E Kuhlisch, T Temelkova-Kurktschiev, E Henkel, C Köhler, S Gehrisch, G Siegert |
Blood Coagulation & Fibrinolysis | 2003 |
Hormone therapy and venous thromboembolism
RE Peverill |
Best Practice & Research Clinical Endocrinology & Metabolism | 2003 |
Comparison of Standard PCR and the LightCycler® Technique to Determine the Thrombophilic Mutations: An Efficiency and Cost Study
B Schroell-Metzger, M Dicato, M Bosseler, G Berchem |
Clinical Chemistry and Laboratory Medicine | 2003 |
Activated protein C resistance determined with a thrombin generation-based test predicts for venous thrombosis in men and women
G Tans, AH Vlieg, MC Thomassen, J Curvers, RM Bertina, J Rosing, FR Rosendaal |
British Journal of Haematology | 2003 |
The Effect of Lupus Anticoagulant in the Second-Generation Assay for Activated Protein C Resistance
BD Ragland, CE Reed, BM Eiland, PH Tichenor, CL Hudson, GA Fritsma, BK Adler, MB Marques |
American Journal of Clinical Pathology | 2003 |
Influence of factor V Leiden on the development of neovascularisation secondary to central retinal vein occlusion
C Hvarfner, A Hillarp, J Larsson |
The British journal of ophthalmology | 2003 |
Factor V Leiden—the commonest molecular defect in arterial and venous thrombophilia in India
RP Ahmed, PK Gupta, M Kannan, VP Choudhry, R Saxena |
Thrombosis Research | 2003 |
Activated protein C resistance (FVLeiden) and thrombosis: factor V mutations causing hypercoagulable states
GA Nicolaes, B Dahlbäck |
Hematology/Oncology Clinics of North America | 2003 |
Factor V Leiden: A Review of the Literature
L Ament |
The Journal of Perinatal & Neonatal Nursing | 2003 |
Deep veinous thrombosis following uneventful phacoemulsification
T Ong, P Trancos, J Jagger |
Journal of Cataract & Refractive Surgery | 2003 |
Increased incidence of thrombophilic abnormalities in patients with cranial dural arteriovenous fistulae
R Gerlach, H Yahya, S Rohde, M Böhm, J Berkefeld, I Scharrer, V Seifert, A Raabe |
Neurological Research | 2003 |
Genetically Determined Procoagulant States and Heparin Use
RD McBane |
Seminars in cardiothoracic and vascular anesthesia | 2003 |
Susceptibility to pre-eclampsia in Finnish women is associated with R485K polymorphism in the factor V gene, not with Leiden mutation
F Faisel, EL Romppanen, M Hiltunen, S Helisalmi, J Laasanen, K Punnonen, JT Salonen, S Heinonen |
European Journal of Human Genetics | 2003 |
Epidémiologie de la thrombose veineuse
J Emmerich |
Bulletin de l'Académie nationale de médecine | 2003 |
Risk factors for thromboembolism in teens: when should I test?
AE Sass, EJ Neufeld |
Current Opinion in Pediatrics | 2002 |
Thrombophilias and Recurrent Miscarriage
AM Adelberg, JA Kuller |
Obstetrical & Gynecological Survey | 2002 |
Response to activated protein C decreases throughout pregnancy
C Benedetto, L Marozio, AM Tavella, V Maula, D Carmignani, A Curti |
Acta Obstetricia et Gynecologica Scandinavica | 2002 |
The effect of factor V Leiden carriage on maternal and fetal health
D Bloomenthal, P Dadelszen, R Liston, L Magee, P Tsang |
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne | 2002 |
Facteurs génétiques de risque de thrombose
J Emmerich, M Aiach |
Annales de Cardiologie et d Angéiologie | 2002 |
Thrombophlébite cérébrale : étude rétrospective de vingt-sept cas
S Rosenstingl, M Ruivard, E Melon, A Schaeffer, M Gouault-Heilmann |
La Revue de Médecine Interne | 2002 |
Importancia de la hipercoagulabilidad en la cirugía de la isquemia crónica de extremidades inferiores
S Cáncer-Pérez, F Acín-García, A Fernández-Heredero, L Benito-Fernández, A Bueno-Bertomeu, J Alfayate-García, JR March-García, AL de Carlos |
Angiología | 2002 |
A 9-year retrospective assessment of laboratory testing for activated protein C resistance: evolution of a novel approach to thrombophilia investigations
EJ Favaloro, I Orsag, M Bukuya, D Mcdonald |
Pathology | 2002 |
Functional characterization of recombinant FV Hong Kong and FV Cambridge
E Norstrøm, E Thorelli, B Dahlbäck |
Blood | 2002 |
Naturally occurring mutations in the thrombomodulin gene leading to impaired expression and function
G Kunz, AK Öhlin, A Adami, B Zöller, P Svensson, DA Lane |
Blood | 2002 |
Clinical Utility of Factor V Leiden (R506Q) Testing for the Diagnosis and Management of Thromboembolic Disorders
RD Press, KA Bauer, JL Kujovich, JA Heit |
Archives of pathology & laboratory medicine | 2002 |
Monocytes, but not endothelial cells, downregulate the anticoagulant activity of activated protein C
M Colucci, AM Stramaglia, E Mascolo, E Napoleone, R Lorenzet, N Semeraro |
British Journal of Haematology | 2001 |
G20210A prothrombin gene mutation identified in patients with venous leg ulcers
G Jebeleanu, L Procopciuc |
Journal of Cellular and Molecular Medicine | 2001 |
Thrombophilic factors in chronic thromboembolic pulmonary hypertension
CC Colorio, ME Martinuzzo, RR Forastiero, G Pombo, Y Adamczuk, LO Carreras |
Blood Coagulation and Fibrinolysis | 2001 |
Impact of the factor II: G20210A variant on the risk of venous thromboembolism in relatives from families with the factor V: R506Q mutation
C Rintelen, I Pabinger, P Bettelheim, K Lechner, PA Kyrle, P Knobl, B Schneider, C Mannhalter |
European Journal of Haematology | 2001 |
Consistent Lowering of Clotting Factors for the Treatment of Acute Cardiovascular Syndromes and Hypercoagulability: A Different Pathophysiological Approach
BR Jaeger, P Goehring, J Schirmer, S Uhrig, P Lohse, E Kreuzer, B Reichart, D Seidel |
Therapeutic Apheresis and Dialysis | 2001 |
Investigation and management of heritable thrombophilia
ID Walker, M Greaves, FE Preston |
British Journal of Haematology | 2001 |
Anti- and Procoagulant Activities in Factor VII-Deficient Subjects
J Astermark, L Tengborn, U Hedner, E Berntorp |
Thrombosis Research | 2001 |
Update on selected inherited venous thrombotic disorders
RS Robetorye, GM Rodgers |
American Journal of Hematology | 2001 |
Failure in the Detection of Aberrant mRNA from the Heterozygotic Splice Site Mutant Allele for Protein S in a Patient with Protein S Deficiency
H Iida, M Nakahara, K Komori, M Fujise, M Wakiyama, M Urata, S Kinoshita, H Tsuda, K Sugimachi, N Hamasaki |
Thrombosis Research | 2001 |
Major and Potential Prothrombotic Genotypes in a Cohort of Patients With Venous Thromboembolism
ML Varela, YP Adamczuk, RR Forastiero, ME Martinuzzo, GS Cerrato, G Pombo, LO Carreras |
Thrombosis Research | 2001 |
Prevalence of the factor V Leiden mutation in human inflammatory bowel disease with different activity
Z Nagy, Á Nagy, O Karádi, M Figler, G Rumi, G Sütő, Á Vincze, A Pár, G Mózsik |
Journal of Physiology-Paris | 2001 |
Prevalence and Significance of Thrombophilia in Peripheral Arterial Disease
PJ Burns, DA Mosquera, AW Bradbury |
European Journal of Vascular and Endovascular Surgery | 2001 |
The Impact of Factor V Mutation on the Risk for Occlusion in Patients Undergoing Peripheral Vascular Reconstructions
ES Sampram, B Lindblad |
European Journal of Vascular and Endovascular Surgery | 2001 |
PREVALENCE OF FACTOR V LEIDEN AND ACTIVATED PROTEIN C RESISTANCE IN CENTRAL RETINAL VEIN OCCLUSION:
TM Johnson, S ELDEFRAWY, WG Hodge, BC Leonard, PJ Kertes, SA Taylor, DP Lillicrap |
Retina | 2001 |
Thrombophilia and Obstetrical Outcomes
M Walker, G Smith, M Rodger, J Kingdom |
Journal SOGC | 2001 |
Two common genetic thrombotic risk factors: Factor V Leiden and prothrombin G20210A in adult Turkish patients with thrombosis
A Gurgey, IC Haznedaroglu, T Egesel, Y Buyukask, OI Ozcebe, N Saynalp, SV Dundar, Y Bayraktar |
American Journal of Hematology | 2001 |
Normalization of haemoglobin concentration with recombinant erythropoietin has minimal effect on blood haemostasis
AG Christensson, BG Danielson, SR Lethagen |
Nephrology Dialysis Transplantation | 2001 |
Laboratory Investigation of Thrombophilia
A Tripodi, PM Mannucci |
Clinical chemistry | 2001 |
Combined Factor V Leiden and Prothrombin Genotyping in Patients Presenting With Thromboembolic Episodes
JA Friedline, E Ahmad, D Garcia, D Blue, N Ceniza, JC Mattson, D Crisan |
Archives of pathology & laboratory medicine | 2001 |
Genetic analysis of factor V Leiden in a family with history of thrombosis and venous leg ulcers
LM Procopciuc, C Has, C Drugan, G Jebeleanu |
Journal of Cellular and Molecular Medicine | 2000 |
Familial thrombophilia and retinal vein occlusion
O Backhouse, L Parapia, I Mahomed, D Lee |
Eye | 2000 |
The Role of Natural Anticoagulant Deficiencies and Factor V Leiden in the Development of Idiopathic Portal Vein Thrombosis
T Egesel, Y Büyükaṣk, SV Dündar, A Gürgey, Ṣ Kirazl, Y Bayraktar |
Journal of Clinical Gastroenterology | 2000 |
Obstetric Implications of Activated Protein C Resistance and Factor V Leiden Mutation
RB Gherman, TM Goodwin |
Obstetrical & Gynecological Survey | 2000 |
Left Brachial Artery Thrombus, Left Axillary Vein Thrombus, and Stroke in a Neonate With Factor V Leiden Mutation
KJ Broxterman, P Mathew, L Chicoine |
Journal of Pediatric Hematology/Oncology | 2000 |
Factor V Leiden: the venous thrombotic risk in thrombophilic families
R Lensen, F Rosendaal, JV And, R Bertina |
British Journal of Haematology | 2000 |
Thrombophilia in pregnancy
ID Walker |
Journal of clinical pathology | 2000 |
Criteria for evaluating evidence that laboratory abnormalities are associated with the development of venous thromboembolism
SM Bates, JS Ginsberg, SE Straus, H Rekers, DL Sackett |
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne | 2000 |
Frequency of Polymorphisms in the B-domain of Factor V Gene in APC-resistant Patients
H Kostka, G Siegert, T Schwarz, S Gehrisch, E Kuhlisch, S Schellong, W Jaross |
Thrombosis Research | 2000 |
The Decanucleotide Insertion/Deletion Polymorphism in the Promoter Region of the Coagulation Factor VII Gene and the Risk of Familial Myocardial Infarction
AD Castelnuovo, A D'Orazio, C Amore, A Falanga, MB Donati, L Iacoviello |
Thrombosis Research | 2000 |
¿Trombofilia y enfermedad de Perthes?
JM Puigbert, CA Martínez, MA Canyadell, IN Fusté, PV Valentín, JJ Aramburu |
Anales de Pediatría | 2000 |
Combined Genetic Defect (Homogeneity for Factor V Leiden and Heterogeneity for Prothrombin G20210A Allele), in a Young Patient, with Recurrent Deep Vein Thrombosis and Serious Postphlebitic Syndrome: A Case Report
H Ioannou, A Eleftheriou, V Nousias, C Basioukas, G Kakosimos, C Batsis, G Vartholomatos, M Mitsis |
Angiology | 2000 |
From Molecule to Men
M Zehender, H Just, G Breithardt |
2000 | |
Intrauterine Growth Restriction
J Kingdom, P Baker |
2000 | |
Proteolytic processing of human coagulation factor IX by plasmin
JA Samis, GD Ramsey, JB Walker, ME Nesheim, AR Giles |
Blood | 2000 |
Occlusive Vascular Diseases in Oral Contraceptive Users: Epidemiology, Pathology and Mechanisms
IF Godsland, U Winkler, O Lidegaard, D Crook |
Drugs | 2000 |
Leiden mutation in patients with Crohn’s disease
Z Nagy, Á Nagy, O Karádi, M Figler, G Sütö, A Vincze, A Pár, G Mózsik |
Inflammopharmacology | 1999 |
Influence of three potential genetic risk factors for thrombosis in 43 families carrying the factor V Arg 506 to Gln mutation
VL Cam-Duchez, S Gandrille, D Tregouet, M Alhenc-Gelas, J Emmerich, JN Fiessinger, JY Borg, M Aiach |
British Journal of Haematology | 1999 |
Thrombophilia
MV Huisman, F Rosendaal |
Current Opinion in Hematology | 1999 |
Acquired APC resistance and oral contraceptives: differences between two functional tests
J Curvers, MC Thomassen, GA Nicolaes, R Oerle, K Hamulyak, C HEMKER, G Tans, J Rosing |
British Journal of Haematology | 1999 |
Pseudohomozygosity for activated protein C resistance is a risk factor for venous thrombosis
G Castaman, A Tosetto, M Ruggeri, F Rodeghiero |
British Journal of Haematology | 1999 |
Effects of oral contraceptives on hemostasis and thrombosis
J Rosing, G Tans |
American Journal of Obstetrics and Gynecology | 1999 |
Thrombophilia: a genetic predisposition to thrombosis
RA Sacher |
Transactions of the American Clinical and Climatological Association | 1999 |
The Effect of Short-Term Cold Exposure on Risk Factors for Cardiovascular Disease
JB Mercer, B Østerud, T Tveita |
Thrombosis Research | 1999 |
Expérience d'un laboratoire d'hôpital général en biologie moléculaire
N Profizi, C Poggi, L Chollet |
Revue Française des Laboratoires | 1999 |
Thrombosis Involving the Major Veins with Heterozygote Factor V Leiden Mutation as the Only Risk Factor
SL Tokgözoğlu, T Açil, IC Haznedaroglu, K Aytemir, MK Batur |
Clinical and Applied Thrombosis/Hemostasis | 1999 |
Mesenteric vein thrombosis due to factor V Leiden gene mutation
M Bergenfeldt, PJ Svensson, A Borgstrom |
The British journal of surgery | 1999 |
A possible role for activated protein C resistance in patients with first and second trimester pregnancy failure
J Tal, LM Schliamser, Z Leibovitz, G Ohel, D Attias |
Human Reproduction | 1999 |
The Influence of Developmental Haemostasis on the Laboratory Diagnosis and Management of Haemostatic Disorders During Infancy and Childhood
C Male, M Johnston, C Sparling, LA Brooker, M Andrew, P Massicotte |
Clinics in Laboratory Medicine | 1999 |
Poor Response to Activated Protein C as a Prominent Risk Predictor of Advanced Atherosclerosis and Arterial Disease
S Kiechl, A Muigg, P Santer, M Mitterer, G Egger, M Oberhollenzer, F Oberhollenzer, A Mayr, A Gasperi, W Poewe, J Willeit |
Circulation | 1999 |
Antithrombotics
AC Uprichard, KP Gallagher |
1999 | |
Cleavage of Factor V at Arg 506 by Activated Protein C and the Expression of Anticoagulant Activity of Factor V
E Thorelli, RJ Kaufman, B Dahlbäck |
Blood | 1999 |
Activated Protein C Resistance: Effect of Platelet Activation, Platelet-Derived Microparticles, and Atherogenic Lipoproteins
J Taube, N McWilliam, R Luddington, CD Byrne, T Baglin |
Blood | 1999 |
A Reduced Sensitivity for Activated Protein C in the Absence of Factor V Leiden Increases the Risk of Venous Thrombosis
MC de Visser, FR Rosendaal, RM Bertina |
Blood | 1999 |
No Prognostic Importance of Resistance to Activated Protein C in Unstable Coronary Artery Disease Despite Signs of Thrombin Activation
Toss, Ernofsson, Wallentin, Seigbahn |
Journal of Thrombosis and Thrombolysis | 1999 |
EARLY LOSS OF RENAL TRANSPLANTS IN PATIENTS WITH THROMBOPHILIA
M Fischereder, P G??hring, H Schneeberger, P Lohse, KV Appen, W Samtleben, D Schl??ndorff, W Land |
Transplantation | 1998 |
Low risk of venous thrombosis in two families with combined type I plasminogen deficiency and factor V R506Q mutation
G Castaman, M Ruggeri, A Tosetto, F Rodeghiero |
American Journal of Hematology | 1998 |
The Role of Activated Protein C Resistance in the Pathogenesis of Venous Thrombosis
WC Hooper, BL Evatt |
The American Journal of the Medical Sciences | 1998 |
No Correlation between Activated Protein C Resistance and Free Flap Failures in 100 Consecutive Patients
B Arnljots, T Söderström, H Svensson |
Plastic & Reconstructive Surgery | 1998 |
Production of phospholipid antibodies in selected thrombophilic women differing in genotype at the 506 site of factor V
MI Bokarewa, K Bremme |
European Journal of Haematology | 1998 |
Activated protein C resistance in patients with peripheral vascular disease
ES Sampram, B Lindblad, B Dahlbäck |
Journal of Vascular Surgery | 1998 |
Changes of Resistance to Activated Protein C in The Course of Pregnancy and Prevalence of Factor V Mutation
S Mimuro, R Lahoud, L Beutler, B Trudinger |
The Australian and New Zealand Journal of Obstetrics and Gynaecology | 1998 |
Polymorphisms in the Coagulation Factor VII Gene and the Risk of Myocardial Infarction
L Iacoviello, AD Castelnuovo, P Knijff, A D'Orazio, C Amore, R Arboretti, C Kluft, MB Donati |
New England Journal of Medicine | 1998 |
Pulmonary Embolism
SZ Goldhaber |
New England Journal of Medicine | 1998 |
The Arg506Gln Mutation (FV Leiden) Among a Cohort of 4188 Unselected Danish Newborns
TB Larsen, JF Lassen, I Brandslund, L Byriel, GB Petersen, B Nørgaard-Pedersen |
Thrombosis Research | 1998 |
New DNA Diagnostic System for Detection of Factor V Leiden
LI Patrushev, ES Zykova, AL Kayushin, MD Korosteleva, AI Miroshnikov, IN Bokarew, SG Leont’ev, VM Koshkin, ES Severin |
Thrombosis Research | 1998 |
Evaluation of Role of Factor V Leiden Mutation in Fatal Pulmonary Thromboembolism
ST Dunn, S Trong |
Thrombosis Research | 1998 |
Effect of Anticoagulant Therapy on the Hypercoagulable State in Patients Carrying the Factor V Arg506Gln Mutation
TB Larsen, JF Lassen, BS Dahler-Eriksen, PH Petersen, I Brandslund |
Thrombosis Research | 1998 |
Guidelines for antithrombotic therapy in pediatric patients
M Andrew, AD Michelson, E Bovill, M Leaker, MP Massicotte |
The Journal of Pediatrics | 1998 |
Stroke in a Neonate Heterozygous for Factor V Leiden
PN MD, BJ MD, HM MD, GS MD, LR MD |
Pediatric Neurology | 1998 |
Thrombophilia and Activated Protein C Resistance
CH Selzman, TA Whitehill, WC Krupski |
Annals of Vascular Surgery | 1998 |
Activated protein C resistance and deficiencies of antithrombin III, protein C or protein S and the risk of thromboembolic disease in users of oral contraceptives
UH Winkler |
The European Journal of Contraception and Reproductive Health Care | 1998 |
Deep Venous Thrombosis in a Preterm Newborn of a Mother with Activated Protein C Resistance
Y Finkelstein, D Aloni, A Kimia, R Sommer, L Sirota |
Clinical Pediatrics | 1998 |
Klinische Angiologie
H Rieger, W Schoop |
1998 | |
Factor V Cambridge: A New Mutation (Arg306→Thr) Associated With Resistance to Activated Protein C
D Williamson, K Brown, R Luddington, C Baglin, T Baglin |
Blood | 1998 |
Platelet-Derived Factor Va/VaLeiden Cofactor Activities Are Sustained on the Surface of Activated Platelets Despite the Presence of Activated Protein C
RM Camire, M Kalafatis, P Simioni, A Girolami, PB Tracy |
Blood | 1998 |
The A20210 Allele of the Prothrombin Gene Is Frequently Associated With the Factor V Arg 506 to Gln Mutation But Not With Protein S Deficiency in Thrombophilic Families
B Zöller, PJ Svensson, B Dahlbäck, A Hillarp |
Blood | 1998 |
Ensuring Accurate Molecular Genetic Testing
M McGovern |
Clinical chemistry | 1998 |
Activated protein C resistance, thrombophilia, and inflammatory bowel disease
M A Heneghan, B Cleary, M Murray, T A O'Gorman, C F McCarthy |
Digestive Diseases and Sciences | 1998 |
Detection of a common mutation in factor V gene responsible for resistance to activated protein C causing predisposition to thrombosis
Ferreira\u2010Gonzalez A, Fisher L, Lehman C, Langley M, Lofland D, Xia Q, Nguyen N, Modesto D, Willoughby J, Wilkinson D, Garrett C |
Journal of Clinical Laboratory Analysis | 1998 |
Detection of a common mutation in factor V gene responsible for resistance to activated protein C causing predisposition to thrombosis
A Ferreira-Gonzalez, LM Fisher, CM Lehman, MH Langley, DH Lofland, Q Xia, NX Nguyen, D Modesto, JB Willoughby, DS Wilkinson, CT Garrett |
Journal of Clinical Laboratory Analysis | 1997 |
Factor V Leiden mutation: An unrecognized cause of hemiplegic cerebral palsy, neonatal stroke, and placental thrombosis
O Thorarensen, S Ryan, J Hunter, DP Younkin |
Annals of Neurology | 1997 |
Prevalence of factor V Leiden mutation in various populations
FH Herrmann, M Koesling, W Schröder, R Altman, RJ Bonilla, S Lopaciuk, JL Perez-Requejo, JR Singh |
Genetic Epidemiology | 1997 |
Factor V Leiden (R506Q) and risk of venous thromboembolism: a case-control study based on the Spanish population
JM García-Gala, V Alvarez, CR Pinto, I Soto, MF Urgellés, MJ Menéndez, C Carracedo, C López-Larrea, E Coto |
Clinical Genetics | 1997 |
Inherited thrombotic disorders: An update
SR Florell, GM Rodgers |
American Journal of Hematology | 1997 |
Changes in activated protein C resistance during normal pregnancy
MC Walker, PR Garner, EJ Keely, GA Rock, MD Reis |
American Journal of Obstetrics and Gynecology | 1997 |
Activated protein C resistance and adverse pregnancy outcome
S Rotmensch, M Liberati, M Mittelmann, Z Ben-Rafael |
American Journal of Obstetrics and Gynecology | 1997 |
Preeclampsia is associated with a reduced response to activated protein C
C Lindoff, I Ingemarsson, G Martinsson, M Segelmark, H Thysell, B Åstedt |
American Journal of Obstetrics and Gynecology | 1997 |
Venous thrombosis: factor V G1691A genotyping related to APC resistance as measured by 2 methods
A Alderborn, A Siegbahn, C Wadelius |
European Journal of Haematology | 1997 |
ACTIVATED PROTEIN C RESISTANCE DUE TO A COMMON FACTOR V GENE MUTATION IS A MAJOR RISK FACTOR FOR VENOUS THROMBOSIS
BZ MD, AH PhD, EB MD, BD MD |
Annual Review of Medicine | 1997 |
Venous thrombosis after Caesarean section in a young woman with homozygous APC resistance and type I protein S deficiency
FD Biasiutti, B Stucki, M Solenthaler, A Tobler, M Furlan, B Lämmle |
European Journal of Haematology | 1997 |
Impact of activated protein C resistance on general vascular surgical patients
MC Donaldson, M Belkin, AD Whittemore, JA Mannick, JA Longtine, DM Dorfman |
Journal of Vascular Surgery | 1997 |
Activated protein C resistance in patients with central retinal vein occlusion
J Larsson, A Sellman, B Bauer |
The British journal of ophthalmology | 1997 |
Dural puncture and activated protein C resistance: risk factors for cerebral venous sinus thrombosis
E Wilder-Smith, I Kothbauer-Margreiter, B Lämmle, M Sturzenegger, C Ozdoba, SP Hauser |
Journal of neurology, neurosurgery, and psychiatry | 1997 |
Prevalence of the factor V Leiden mutation in hepatic and portal vein thrombosis
AE Mahmoud, E Elias, N Beauchamp, JT Wilde |
Gut | 1997 |
Plasma resistance to activated protein C regulates the activation of coagulation induced by thrombolysis in patients with ischaemic heart disease
OD Pedersen, J Gram, J Jespersen |
Heart (British Cardiac Society) | 1997 |
AN ALTERNATIVE METHOD FOR IDENTIFYING THE FACTOR V GENE LEIDEN MUTATION
K Lewandowski, M Rożek, K Zawilska, WT Markiewicz |
Thrombosis Research | 1997 |
EVALUATION OF A NEW CHRONOMETRIC ASSAY FOR FACTOR V LEIDEN - DEPENDENT APC RESISTANCE
M Gouault-Heilmann, C Leroy-Matheron |
Thrombosis Research | 1997 |
ACTIVATED PROTEIN C RESISTANCE CAUSED BY A COMMON FACTOR V MUTATION HAS A SINGLE ORIGIN
B Zöller, A Hillarp, B Dahlbäck |
Thrombosis Research | 1997 |
Activated protein C resistance caused by factor V gene mutation: Common coagulation defect in chronic venous leg ulcers?
D Peus, JA Heit, MR Pittelkow |
Journal of the American Academy of Dermatology | 1997 |
Activated protein C resistance and anticardiolipin antibodies in patients with venous leg ulcers
D Grossman, PW Heald, C Wang, HM Rinder |
Journal of the American Academy of Dermatology | 1997 |
2 Congenital thrombophilia
ID Walker |
Baillière's Clinical Obstetrics and Gynaecology | 1997 |
Thrombosis prophylaxis after treatment during pregnancy
G Daskalakis, A Antsaklis, I Papageorgiou, S Michalas |
European Journal of Obstetrics & Gynecology and Reproductive Biology | 1997 |
Fibrinolysis in patients with the 1691 G→A mutation in factor V gene and history of deep vein thrombosis
M Stegnar, P Peternel, P Uhrin, T Cvelbar-Marinko, K Goršič-Tomažic, BR Binder |
Fibrinolysis and Proteolysis | 1997 |
Screening for Resistance to Activated Protein C and the Mutant Gene for Factor V:Q506 in Patients With Central Retinal Vein Occlusion
AK Vine, MM Samama |
American Journal of Ophthalmology | 1997 |
The inherited basis of venous thrombosis
RD Appleby, RJ Olds |
Pathology | 1997 |
Venous Thromboembolism in Heterozygotes for Factor V Leiden—The Second-Hit Hypothesis: A Report of Two Patients and a Review of the English-Language Literature
HD Pak, AL Perrotta |
Clinical and Applied Thrombosis/Hemostasis | 1997 |
State-of-the-Art Review: Activated Protein C Resistance: Clinical Implications
B Zöller, A Hillarp, B Dahlbäck |
Clinical and Applied Thrombosis/Hemostasis | 1997 |
Molecular Genetics of Factor V Leiden: Genetic Origins and Modern DNA-Based Detection Strategies
C Maher, C Wall, S Fanning |
Seminars in cardiothoracic and vascular anesthesia | 1997 |
Intra-Atrial Thrombosis and Homozygous Factor V Leiden Mutation
P Simioni, D Scalia, D Tormene, S Bongiovi, C Sardella, A Girolami |
Clinical and Applied Thrombosis/Hemostasis | 1997 |
Resistance to Activated Protein C and Legg-Perthes Disease:
CJ Glueck, G Brandt, R Gruppo, A Crawford, D Roy, T Tracy, D Stroop, P Wang, A Becker |
Clinical Orthopaedics and Related Research® | 1997 |
Familial thrombophilia: genetic risk factors and management
M Makris, F Rosendaal, F Preston |
Journal of Internal Medicine | 1997 |
Factor V Leiden and Thrombophilia
M Kalafatis, KG Mann |
Arteriosclerosis, thrombosis, and vascular biology | 1997 |
Resistance to activated protein C caused by the R 506 Q mutation in the gene for factor V is a common risk factor for venous thrombosis
B Dahlbäck |
Journal of Internal Medicine | 1997 |
Gene Transfer in the Cardiovascular System
KL March |
1997 | |
Human Protein C Receptor Is Present Primarily on Endothelium of Large Blood Vessels: Implications for the Control of the Protein C Pathway
Z Laszik, A Mitro, FB Taylor, G Ferrell, CT Esmon |
Circulation | 1997 |
Advances in Critical Care Testing
WF List, MM Müller, MJ McQueen |
1997 | |
The Carbohydrate Moiety of Factor V Modulates Inactivation by Activated Protein C
JA Fernández, TM Hackeng, K Kojima, JH Griffin |
Blood | 1997 |
Genetic and Phenotypic Analysis of a Large (122-Member) Protein S–Deficient Kindred Provides an Explanation for the Familial Coexistence of Type I and Type III Plasma Phenotypes
RE Simmonds, B Zöller, H Ireland, E Thompson, PG de Frutos, B Dahlbäck, DA Lane |
Blood | 1997 |
Human Factor Va 1 and Factor Va 2 : Properties in the Procoagulant and Anticoagulant Pathways
L Hoekema, GA Nicolaes, HC Hemker, G Tans, J Rosing |
Biochemistry | 1997 |
Population study of the G1691A mutation (R506% FV Leiden) in the human factor V gene that is associated with resistance to activated protein C
A Braun, B Müller, AA Rosche |
Human Genetics | 1996 |
Are we ready for factor V Leiden screening?
B Dahlbäck |
The Lancet | 1996 |
ARMS test for diagnosis of factor VLeiden mutation, a common cause of inherited thrombotic tendency
CN Yandava, DC Zappulla, BR Korf, EJ Neufeld |
Journal of Clinical Laboratory Analysis | 1996 |
Arterial and venous thrombosis in two Italian families with the factor V Arg506→ Gln mutation
B Montaruli, J Voorberg, G Tamponi, A Borchielli, G Muleo, A Pannocchia, JA Mourik, P Schinco |
European Journal of Haematology | 1996 |
Strikes in French public transport and resistance to activated protein C
V Eschwège, A Robert |
The Lancet | 1996 |
Molecular mechanisms of activated protein C resistance. Properties of factor V isolated from an individual with homozygosity for the Arg506 to Gln mutation in the factor V gene
C Aparicio, B Dahlbäck |
Biochemical Journal | 1996 |
An assessment of the comparative utility of functional and molecular level analyses in the investigation of patients with thrombophilia
B Clark, C Caine, EN McSweeney, BA McVerry, HC Gooi |
Clinical molecular pathology | 1996 |
Case 12-1996 : An 18-year-old woman with hepatomegaly and ascites
RC Cabot, RE Scully, EJ Mark, WF McNeely, SH Ebeling, KA Bauer, FM Graeme-Cook |
New England Journal of Medicine | 1996 |
Absence of factor V Leiden in the Japanese
T Ozawa, K Niiya, N Sakuragawa |
Thrombosis Research | 1996 |
FACTOR V LEIDEN INCREASES THE RISK OF THROMBOSIS IN PATIENTS WITH ANTIPHOSPHOLIPID ANTIBODIES
R Simantov, SK Lo, JE Salmon, LR Sammaritano, RL Silverstein |
Thrombosis Research | 1996 |
OLIGONUCLEOTIDE LIGATION ASSAY FOR DETECTION OF THE FACTOR V MUTATION (Arg506→Gln) CAUSING PROTEIN C RESISTANCE
JM Benson, DJ Phillips, BP Holloway, BL Evatt, WC Hooper |
Thrombosis Research | 1996 |
Indications and drugs for anticoagulation therapy in children
M Andrew |
Thrombosis Research | 1996 |
Resistance to activated protein C: role in venous and arterial thrombosis
J Emmerich, M Alhenc-Gelas, M Aiach, JN Fiessinger |
Biomedicine & Pharmacotherapy | 1996 |
Activated Protein C Resistance and Thrombosis
WL Nichols, JA Heit |
Mayo Clinic Proceedings | 1996 |
Activated protein C resistance as a basis for venous thrombosis
A Hillarp, B Zöller, B Dahlbäck |
The American Journal of Medicine | 1996 |
Neonatal purpura fulminans in association with factor V R506Q mutation
SW Pipe, AH Schmaier, WC Nichols, D Ginsburg, ME Bozynski, VP Castle |
The Journal of Pediatrics | 1996 |
Pulmonary embolism and deep venous thrombosis during pregnancy or oral contraceptive use: Prevalence of factor V Leiden
DR Hirsch, KM Mikkola, PW Marks, EA Fox, DM Dorfman, BM Ewenstein, SZ Goldhaber |
American Heart Journal | 1996 |
Influence of blood handling on determination of plasma resistance against activated protein C
OD Pedersen, J Sidelmann, J Gram, J Jespersen |
Fibrinolysis | 1996 |
Familial thrombophilia: Clinical and molecular analysis of Swedish families with inherited resistance to activated protein C or protein S deficiency
B Zöller |
Scandinavian Journal of Clinical & Laboratory Investigation | 1996 |
Resistance to activated protein C due to a factor V gene mutation
B Zöller, J Holm, B Dahlbäck |
Trends in Cardiovascular Medicine | 1996 |
Factor V:Q506 mutation and anticardiolipin antibodies in systemic lupus erythematosus
A Bengtsson, B Zöller, PG Frutos, B Dahlbäck, G Sturfelt |
Lupus | 1996 |
Coagulation for Blood Bankers
JR Stubbs |
Clinics in Laboratory Medicine | 1996 |
Resistance to Activated Protein C and A Novel Factor V Gene Mutation
KV Voelkerding |
Clinics in Laboratory Medicine | 1996 |
Activated Protein C Resistance in Ischemic Stroke Not Due to Factor V Arginine 506 →Glutamine Mutation
M Fisher, JA Fernández, SF Ameriso, D Xie, A Gruber, A Paganini-Hill, JH Griffin |
Stroke; a journal of cerebral circulation | 1996 |
Ischemic Stroke in the Elderly: Role of the Common Factor V Mutation Causing Resistance to Activated Protein C
RD Press, XY Liu, N Beamer, BM Coull |
Stroke; a journal of cerebral circulation | 1996 |
25. Hämophilie-Symposion Hamburg 1994
I Scharrer, W Schramm |
1996 | |
Recognition and management of the hypercoagulable states: A decade of change
SH Goodnight, TG DeLoughery, RD Press |
Journal of Thrombosis and Thrombolysis | 1996 |
Activated protein C and retinal vein occlusion
BJ Hunt |
The British journal of ophthalmology | 1996 |
Actuated protein C resistance: From phenotype to genotype and clinical practice
A Hillarp, B Dahlbäck, B Zöller |
Blood Reviews | 1995 |
A chromogenic assay for activated protein C resistance
K Varadi, B Moritz, H Lang, K Bauer, E Preston, I Peake, GE Rivard, B Keil, HP Schwarz |
British Journal of Haematology | 1995 |
Resistance to activated protein C as a basis for venous thromboembolism associated with pregnancy and oral contraceptives
M Hellgren, PJ Svensson, B Dahlbäch |
American Journal of Obstetrics and Gynecology | 1995 |
Coagulation assay with improved specificity to factor V mutants insensitive to activated protein C
M Kraus, N Zander, K Fickenscher |
Thrombosis Research | 1995 |
Diagnostic de résistance à la protéine C activée par test chronométrique et par biologie moléculaire
M Trossaërt, N Pourkiani, J Conard, MH Horellou, F Delers, MM Samama |
La Revue de Médecine Interne | 1995 |
Activated protein C resistance in a neonate with venous thrombosis
E Kodish, C Potter, NE Kirschbaum, PA Foster |
The Journal of Pediatrics | 1995 |
Le diagnostic biologique de la résistance à la protéine C activée
M Trossaërt, J Conard, MH Horellou, I Elalamy, MM Samama |
Revue Française des Laboratoires | 1995 |
Molecular Genetics of Venous Thromboembolism
B Dahlbäck |
Annals of Medicine | 1995 |
Antithrombotic Therapy in Children
AD Michelson, E Bovill, M Andrew |
Chest | 1995 |
Biochemical Prototype for Familial Thrombosis: A Study Combining a Functional Protein C Mutation and Factor V Leiden
M Kalafatis, D Lu, RM Bertina, GL Long, KG Mann |
Arteriosclerosis, thrombosis, and vascular biology | 1995 |
Factor V Leiden -- An Unselfish Gene?
KA Hajjar |
New England Journal of Medicine | 1994 |
The molecular genetics of familial venous thrombosis
DN Cooper |
Blood Reviews | 1991 |
Advances in Genetics
BH Bowman, F Yang, GS Adrian |
Advances in genetics | 1988 |